RPL12P3

Across TCGA pan-cancer cohorts, RPL12P3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RPL12P3 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL12P3 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL12P3 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

HNSC, OV, and STAD are the cancer types where RPL12P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.943	0.611	.009	69	view →
OV	OS	Tertile	III,IV	0.798	0.661	<.001	54	view →
STAD	OS	Tertile	IV	0.805	0.283	.031	18	view →
UCEC	DFS	Tertile	All	0.245	0.672	.007	18	view →
PAAD	DFS	Tertile	III,IV	0.275	0.794	.008	15	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
BLCA	OS	Tertile	IV	1.000	0.345	.045	6	view →
LIHC	DFS	Tertile	All	0.786	0.483	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RPL12P3–HNSC (DFS)

Open the HNSC breakdown →